Usage of Vinorelbin ORAL (Navelbine ORAL) in the Treatment of Advanced Non-Small Cell Lung Cancer(NSCLC)and Advanced Breast Cancer
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2012
At a glance
- Drugs Vinorelbine (Primary)
- Indications Advanced breast cancer; Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 29 Jun 2012 Actual patient number 62 added as reported by ClinicalTrials.gov.
- 29 Jun 2012 Actual end date Apr 2012 added as reported by ClinicalTrials.gov.
- 29 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.